Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - PR Newswire
<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxNdE1PQktGUzVHSHh1bjNEZVZmd09oWEp6X0VQdDVfQ01rVk00ZzdQSFpEN0RGaWtSaXZ4WV9xdmtZQWVfSmZQUnE3emhHSmFIcy1zNmdFYUcwVV9ZZ2hDQ2NQRDAyZnNVY016WmVzRU1aX0dpTFM0b1JhaUIzVW0zaFhfVkxYRjRmZ3UyUWxFazctSVVMRmVKSVdiaGJlTmh3NkhwQVlsRUlIekVkdjBrSUZRbjI5ZnhEdHc0MzhrTWU1SWItY2VEMkxTYVBrMVBSR01tamZidnJkSlpXcHZMSnFOX2tXelZmZllSSThsM0NaUXM5RmF4b21fQVdKeHBubGVMZHJ4OA?oc=5" target="_blank">Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for…
